Jennifer J. Rhodes

2023

In 2023, Jennifer J. Rhodes earned a total compensation of $1.4M as former Executive Vice President, Chief Business Officer, General Counsel, Chief Compliance Officer and Corporate Secretary at Elicio Therapeutics, a 77% increase compared to previous year.

Compensation breakdown

Bonus$440,840
Salary$222,257
Other$702,762
Total$1,365,859

Rhodes received $702.8K in other compensation, accounting for 51% of the total pay in 2023.

Rhodes also received $440.8K in bonus and $222.3K in salary.

Rankings

In 2023, Jennifer J. Rhodes' compensation ranked 840th out of 2,647 executives tracked by ExecPay. In other words, Rhodes earned more than 68.3% of executives.

ClassificationRankingPercentile
All
840
out of 2,647
68th
Division
Manufacturing
495
out of 1,447
66th
Major group
Chemicals And Allied Products
340
out of 817
58th
Industry group
Drugs
330
out of 783
58th
Industry
Pharmaceutical Preparations
222
out of 555
60th
Source: SEC filing on September 27, 2024.

Rhodes' colleagues

We found four more compensation records of executives who worked with Jennifer J. Rhodes at Elicio Therapeutics in 2023.

2023

Jay Venkatesan

Elicio Therapeutics

Chief Executive Officer

2023

Brian Piekos

Elicio Therapeutics

Chief Financial Officer

2023

Robert Connelly

Elicio Therapeutics

Chief Executive Officer

2023

Christopher Haqq

Elicio Therapeutics

Chief Medical Officer

News

You may also like